vs
PLUMAS BANCORP（PLBC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是PLUMAS BANCORP的1.2倍（$35.5M vs $28.6M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 35.1%），PLUMAS BANCORP自由现金流更多（$20.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 20.8%）
Plumas Bancorp是一家美国银行控股公司，通过旗下子公司Plumas Bank开展业务，为加利福尼亚州北部及内华达州的个人客户、中小企业和本地社区机构提供存款、各类贷款、财富管理等综合零售及商业银行服务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
PLBC vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.2倍
$28.6M
营收增速更快
RXRX
高出646.7%
35.1%
自由现金流更多
PLBC
多$67.6M
$-47.3M
两年增速更快
RXRX
近两年复合增速
20.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $28.6M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 48.9% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 35.1% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $1.56 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLBCRXRX
| Q4 25 | $28.6M | $35.5M | ||
| Q3 25 | $27.4M | $5.2M | ||
| Q2 25 | $20.5M | $19.2M | ||
| Q1 25 | $21.8M | $14.7M | ||
| Q4 24 | $21.2M | $4.5M | ||
| Q3 24 | $21.1M | $26.1M | ||
| Q2 24 | $20.6M | $14.4M | ||
| Q1 24 | $19.6M | $13.8M |
净利润PLBCRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $5.1M | $-162.3M | ||
| Q2 25 | $6.3M | $-171.9M | ||
| Q1 25 | $7.2M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $7.8M | $-95.8M | ||
| Q2 24 | $6.8M | $-97.5M | ||
| Q1 24 | $6.3M | $-91.4M |
毛利率PLBCRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率PLBCRXRX
| Q4 25 | 48.9% | -304.8% | ||
| Q3 25 | 25.2% | -3327.6% | ||
| Q2 25 | 42.2% | -916.8% | ||
| Q1 25 | 46.1% | -1297.9% | ||
| Q4 24 | 50.3% | -4042.4% | ||
| Q3 24 | 50.6% | -377.1% | ||
| Q2 24 | 45.1% | -697.4% | ||
| Q1 24 | 42.8% | -698.4% |
净利率PLBCRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | 18.8% | -3135.3% | ||
| Q2 25 | 30.8% | -894.2% | ||
| Q1 25 | 33.0% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 37.1% | -367.5% | ||
| Q2 24 | 32.9% | -676.6% | ||
| Q1 24 | 31.9% | -662.4% |
每股收益（稀释后）PLBCRXRX
| Q4 25 | $1.56 | $-0.17 | ||
| Q3 25 | $0.73 | $-0.36 | ||
| Q2 25 | $1.05 | $-0.41 | ||
| Q1 25 | $1.20 | $-0.50 | ||
| Q4 24 | $1.30 | $-0.56 | ||
| Q3 24 | $1.31 | $-0.34 | ||
| Q2 24 | $1.14 | $-0.40 | ||
| Q1 24 | $1.05 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $261.1M | $1.1B |
| 总资产 | $2.2B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资PLBCRXRX
| Q4 25 | $80.6M | $743.3M | ||
| Q3 25 | $87.3M | $659.8M | ||
| Q2 25 | $79.3M | $525.1M | ||
| Q1 25 | $87.3M | $500.5M | ||
| Q4 24 | $82.0M | $594.4M | ||
| Q3 24 | $118.0M | $427.6M | ||
| Q2 24 | $109.9M | $474.3M | ||
| Q1 24 | $128.2M | $296.3M |
总债务PLBCRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益PLBCRXRX
| Q4 25 | $261.1M | $1.1B | ||
| Q3 25 | $245.9M | $1.0B | ||
| Q2 25 | $193.1M | $919.1M | ||
| Q1 25 | $187.6M | $933.9M | ||
| Q4 24 | $177.9M | $1.0B | ||
| Q3 24 | $181.9M | $524.6M | ||
| Q2 24 | $165.2M | $584.4M | ||
| Q1 24 | $161.5M | $401.2M |
总资产PLBCRXRX
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.7B | $726.5M | ||
| Q2 24 | $1.6B | $775.9M | ||
| Q1 24 | $1.6B | $557.8M |
负债/权益比PLBCRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $20.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | 70.9% | -133.1% |
| 资本支出强度资本支出/营收 | 4.6% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $34.4M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流PLBCRXRX
| Q4 25 | $21.6M | $-46.1M | ||
| Q3 25 | $5.6M | $-117.4M | ||
| Q2 25 | $2.1M | $-76.4M | ||
| Q1 25 | $7.5M | $-132.0M | ||
| Q4 24 | $30.5M | $-115.4M | ||
| Q3 24 | $8.0M | $-59.2M | ||
| Q2 24 | $5.1M | $-82.2M | ||
| Q1 24 | $9.2M | $-102.3M |
自由现金流PLBCRXRX
| Q4 25 | $20.3M | $-47.3M | ||
| Q3 25 | $4.8M | $-117.6M | ||
| Q2 25 | $2.0M | $-79.6M | ||
| Q1 25 | $7.3M | $-133.8M | ||
| Q4 24 | $29.8M | $-116.7M | ||
| Q3 24 | $7.8M | $-63.8M | ||
| Q2 24 | $4.8M | $-83.4M | ||
| Q1 24 | $9.0M | $-109.0M |
自由现金流率PLBCRXRX
| Q4 25 | 70.9% | -133.1% | ||
| Q3 25 | 17.5% | -2272.5% | ||
| Q2 25 | 9.9% | -413.9% | ||
| Q1 25 | 33.7% | -907.4% | ||
| Q4 24 | 141.0% | -2567.7% | ||
| Q3 24 | 37.1% | -244.6% | ||
| Q2 24 | 23.5% | -578.5% | ||
| Q1 24 | 45.8% | -789.9% |
资本支出强度PLBCRXRX
| Q4 25 | 4.6% | 3.5% | ||
| Q3 25 | 2.9% | 4.7% | ||
| Q2 25 | 0.2% | 16.4% | ||
| Q1 25 | 0.8% | 12.4% | ||
| Q4 24 | 3.2% | 28.6% | ||
| Q3 24 | 0.7% | 17.5% | ||
| Q2 24 | 1.1% | 8.2% | ||
| Q1 24 | 1.0% | 48.2% |
现金转化率PLBCRXRX
| Q4 25 | — | — | ||
| Q3 25 | 1.09× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 1.04× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.02× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.46× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
